share_log

Galectin Therapeutics | DEF 14A: Definitive proxy statements

SEC announcement ·  Oct 17, 2022 08:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more